Loading...
Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours
Banerji, U Evans, J Biondo, A Germetaki, Theodora Randhawa, M Godfrey, L Leslie, S Jeffrey, P Rigby, M
Banerji, U
Evans, J
Biondo, A
Germetaki, Theodora
Randhawa, M
Godfrey, L
Leslie, S
Jeffrey, P
Rigby, M
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Files
Keywords
Type
Meetings and Proceedings
Citation
Cook N, Banerji U, Evans J, Biondo A, Germetaki T, Randhawa M, et al. 464P Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours. Annals of Oncology. 2019;30(Supplement_5):174.